Visit JCR Japan
Visit JCR Japan
Home
Who we are
Innovation
Pipeline
Patients & families
Our commitment
Partnerships
Investors & media
Our products
Contact us
Moises Zanetti
FY2025-Q3 financial report (Oct. 1-Dec. 31, 2025)
by Moises Zanetti
Revision of consolidated financial forecasts for fiscal year ended March 31, 2026
by Moises Zanetti
Recognition of subsidy income as extraordinary income
by Moises Zanetti
FY2025 third quarter results briefing session material
by Moises Zanetti
Briefing session movie on the agreement with Italfarmaco
by Moises Zanetti
JCR Pharmaceuticals to present at the 22nd Annual WORLD
Symposium
™ 2026
by Moises Zanetti
Briefing session script on the agreement with Italfarmaco
by Moises Zanetti
Briefing session material on the agreement with Italfarmaco
by Moises Zanetti
Information on the 44th J.P. Morgan Healthcare Conference now available
by Moises Zanetti
The 44th J.P.Morgan Healthcare Conference presentation materials
by Moises Zanetti
1
2
3
…
7
Privacy Preference Center
Privacy Preferences
